ADVANCED SOLID TUMORS
Clinical trials for ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ZGGS15 tested in patients with advanced cancers
Disease control CompletedThis early-stage study tested a new drug, ZGGS15, in 22 adults with advanced solid tumors who had no standard treatments left. The main goals were to find a safe dose and check for side effects. Researchers also looked for signs that the drug might shrink tumors.
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Apr 29, 2026 02:39 UTC
-
Immunotherapy breakthrough: one year may be enough for some advanced cancers
Knowledge-focused CompletedThis study looked at 161 people with advanced solid tumors (like lung, bladder, skin, and kidney cancers) who had already been on immunotherapy (PD-1/PD-L1 inhibitors) for one year and whose disease was stable. Half stopped treatment, and half continued. The goal was to see if st…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE3 • Sponsor: Dan Zandberg • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:37 UTC